Filtrar por Last updated date SelectDespués deAntes deFrom - To Fecha Fecha de final Esta semana Este mes la semana pasada El mes pasado Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Deje este campo en blanco Filter Resultados (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Deje este campo en blanco Global regulators celebrate 10 years of strategic leadership and cooperation 9 Noviembre 2023 News Human Medicines First electronic product information (ePI) published for selected human medicines 8 Noviembre 2023 News Data on medicines Product information EMA encourages companies to submit type I variations for 2023 in November 2023 3 Noviembre 2023 News Corporate Medicines Call for expressions of interest for patients’ organisations representatives to join Committee for Orphan Medicinal Products (COMP) 3 Noviembre 2023 News Human Corporate Medicines Call for expression of interest for independent scientific experts to participate in the work of EMA’s Safety Committee 3 Noviembre 2023 News Human Corporate Medicines EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5 31 Octubre 2023 News Human COVID-19 Vaccines EMA business hours over All Saints' Day and All Souls' Day, 1 and 2 November 30 Octubre 2023 News Corporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 October 2023 27 Octubre 2023 News Human Pharmacovigilance Referrals EMA takes further steps to address critical shortages of medicines in the EU 24 Octubre 2023 News Human Medicine shortages EMA alerts EU patients and healthcare professionals to reports of falsified Ozempic pens 18 Octubre 2023 News Human Medicines 1 … 21 22 23 24 25 Page 25 of 380 26 27 28 29 … 380
Global regulators celebrate 10 years of strategic leadership and cooperation 9 Noviembre 2023 News Human Medicines
First electronic product information (ePI) published for selected human medicines 8 Noviembre 2023 News Data on medicines Product information
EMA encourages companies to submit type I variations for 2023 in November 2023 3 Noviembre 2023 News Corporate Medicines
Call for expressions of interest for patients’ organisations representatives to join Committee for Orphan Medicinal Products (COMP) 3 Noviembre 2023 News Human Corporate Medicines
Call for expression of interest for independent scientific experts to participate in the work of EMA’s Safety Committee 3 Noviembre 2023 News Human Corporate Medicines
EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5 31 Octubre 2023 News Human COVID-19 Vaccines
EMA business hours over All Saints' Day and All Souls' Day, 1 and 2 November 30 Octubre 2023 News Corporate
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 October 2023 27 Octubre 2023 News Human Pharmacovigilance Referrals
EMA takes further steps to address critical shortages of medicines in the EU 24 Octubre 2023 News Human Medicine shortages
EMA alerts EU patients and healthcare professionals to reports of falsified Ozempic pens 18 Octubre 2023 News Human Medicines